弥散性血管内凝血及其免疫机制
本文综述弥散性血管内凝血(DIC)的免疫机制。DIC由感染与非感染性病因触发,特征为血管内凝血酶过度生成和纤维蛋白原广泛蛋白水解。临床表现为血栓闭塞性损伤至出血素质,涉及凝血激活、抗凝与纤溶失调及炎症免疫血栓机制。诊断基于量化止血失衡、血小板减少和纤维蛋白原转化的算法,但当前主要评估显性消耗性凝血病,对非显性和前DIC状态识别不足。治疗包括去除诱因和支持治疗,死亡率仍高,需针对病理机制的新策略。
要点
- DIC由感染或非感染病因触发,特征为凝血酶过度生成和纤维蛋白原消耗。
- 诊断基于止血失衡、血小板减少和纤维蛋白原转化的量化算法。
- 当前诊断主要评估显性消耗性凝血病,需提高对非显性和前DIC的识别。
核心结论
- DIC患者死亡率仍高,需针对潜在病理机制的新策略。
- 及时识别DIC对减少病理负担至关重要。
研究设计与样本
- 本文为综述,检索范围未在原文中报告。
主要发现
- DIC临床发展与非显性疾病恶化和死亡率增加相关,无论基础病理如何。
- DIC涉及凝血激活、抗凝消耗、内皮稳态破坏和纤溶失调。
关键数值与推荐
- 诊断基于量化止血失衡、血小板减少和纤维蛋白原转化的算法。
临床怎么用
- 治疗策略包括去除诱发触发因素和对止血失衡的支持治疗。
局限性
- 当前诊断主要评估显性消耗性凝血病,对非显性DIC和前DIC状态识别不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disseminated intravascular coagulation (DIC) is a syndrome triggered by infectious and noninfectious pathologies characterized by excessive generation of thrombin within the vasculature and widespread proteolytic conversion of fibrinogen. Despite diverse clinical manifestations ranging from thrombo-occlusive damage to bleeding diathesis, DIC etiology commonly involves excessive activation of blood coagulation and overlapping dysregulation of anticoagulants and fibrinolysis. Initiation of blood coagulation follows intravascular expression of tissue factor or activation of the contact pathway in response to pathogen-associated or host-derived, damage-associated molecular patterns. The process is further amplified through inflammatory and immunothrombotic mechanisms. Consumption of anticoagulants and disruption of endothelial homeostasis lower the regulatory control and disseminate microvascular thrombosis. Clinical DIC development in patients is associated with worsening morbidities and increased mortality, regardless of the underlying pathology; therefore, timely recognition of DIC is critical for reducing the pathologic burden. Due to the diversity of triggers and pathogenic mechanisms leading to DIC, diagnosis is based on algorithms that quantify hemostatic imbalance, thrombocytopenia, and fibrinogen conversion. Because current diagnosis primarily assesses overt consumptive coagulopathies, there is a critical need for better recognition of nonovert DIC and/or pre-DIC states. Therapeutic strategies for patients with DIC involve resolution of the eliciting triggers and supportive care for the hemostatic imbalance. Despite medical care, mortality in patients with DIC remains high, and new strategies, tailored to the underlying pathologic mechanisms, are needed.
引用
- Popescu NI, Lupu C, Lupu F, et al. Disseminated intravascular coagulation and its immune mechanisms. Blood. 2022. PMID: 34428280. doi:10.1182/blood.2020007208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。